Ultramicrosize Griseofulvin Tablets (Ultramicrosize Griseofulvin)
Tubulin Inhibiting Agent class · 0 generic manufacturers · 0 ANDAs filed at FDA.
Questions a plan sponsor actually asks.
What is Ultramicrosize Griseofulvin Tablets used for?
Ultramicrosize Griseofulvin Tablets is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Ultramicrosize Griseofulvin Tablets?
No. Ultramicrosize Griseofulvin Tablets is brand-only with no generic equivalents currently in market.
How much does my plan pay for Ultramicrosize Griseofulvin Tablets?
Across 329 Part D plans, Ultramicrosize Griseofulvin Tablets averages $3.20/unit (NADAC). Lowest available: $2.65/unit. Highest in distribution: $3.74/unit.
Is Ultramicrosize Griseofulvin Tablets on the FDA shortage list?
No. Ultramicrosize Griseofulvin Tablets is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.